Noom Med vs Willow: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher

52 providers verified independently·Independent researchHow we rank →

Willow beats Noom Med overall, scoring 7.5/10 vs 7.4/10. Noom Med is more affordable at $99/mo vs $299/mo. Choose Noom Med for users who want a tiered entry into glp-1 care, from $99/mo m. Choose Willow for users who want comprehensive clinical support with flexibili.

A side-by-side look at Noom Med and Willow to help you decide. We compare them on:

  • Starting price per month
  • Our overall score, out of 10
  • Medication type, brand-name or compounded
  • Whether they accept insurance
  • Who each one is best for

Noom Med

#27 of 52
7.4/10

Noom restructured Noom Med in 2026 into 3 tiers: $69/mo branded telehealth (med out-of-pocket), $99-149/mo Microdose GLP-1Rx (low-dose + biomarker monitoring), and the Full GLP-1Rx program ($149 intro → $349/mo on 12-week subscription). Coaching app included at every tier.

Visit Noom Med
Higher Rated

Willow

#24 of 52
7.5/10

Personalized GLP-1 weight loss with ongoing clinical support. Compounded semaglutide and tirzepatide only, Willow explicitly does not prescribe brand-name Wegovy or Zepbound. Added oral compounded semaglutide tablets as a non-injectable option.

Visit Willow
FeatureNoom MedWillow
Our Score7.4/107.5/10
Starting Price$99/mo$299/mo
Medication TypeBothCompounded
Insurance AcceptedYesNo
Best ForUsers who want a tiered entry into GLP-1 care, from $99/mo Microdose all-in (low-dose + biomarkers + coaching) up to a full $349/mo medication + coaching programUsers who want comprehensive clinical support with flexibility between injectable and oral compounded semaglutide routes
Ranking#27#24
Get startedVisit Noom MedVisit Willow

Pros & Cons Compared

Noom Med

Pros

  • +Tiered 2026 entry, $69/mo branded telehealth tier lets users start with just medication access and the coaching app
  • +New Microdose GLP-1Rx program ($99-149/mo), low-dose GLP-1 + biomarker monitoring for sensitive users
  • +Insurance accepted for qualifying plans, can significantly reduce out-of-pocket costs on brand-name meds
  • +Industry-leading behavioral coaching app with years of psychology-based weight loss methodology

Cons

  • Tiered pricing creates confusion, $69, $99-149, or $149-349 depending on tier
  • Full GLP-1Rx program requires 12-week subscription ($149 intro rate applies only for the first few weeks)
  • Medication costs on the $69 tier are out-of-pocket, the low tier price is just the platform
  • App coaching still requires real engagement, skip-prone users waste the behavioral value

Willow

Pros

  • +Includes monthly provider check-ins and dose adjustments at no extra cost
  • +Offers both injectable AND oral compounded semaglutide, one of few platforms with a daily oral tablet option
  • +$299/mo all-in for compounded semaglutide with monthly provider support
  • +90%+ patient retention rate after 3 months per their published outcomes data

Cons

  • Compounded-only, no brand-name Wegovy or Zepbound through the platform
  • Tirzepatide pricing reaches $499-$524 at higher doses, starting dose is $399/mo
  • Cash-pay only, no insurance billing, though they provide superbills for FSA/HSA
  • Founded in 2024, less track record than Ro or Hims, though growth has been fast

Our Verdict

Willow edges out Noom Med with a score of 7.5/10 vs 7.4/10. If budget is your priority, Noom Med starts at $99/mo compared to Willow's $299/mo. Noom Med accepts insurance, which can significantly reduce your out-of-pocket costs. Noom Med offers both brand-name and compounded medications, giving you more flexibility. Choose Noom Med if you want: users who want a tiered entry into glp-1 care, from $99/mo microdose all-in (low-dose + biomarkers + coaching) up to a full $349/mo medication + coaching program. Choose Willow if you want: users who want comprehensive clinical support with flexibility between injectable and oral compounded semaglutide routes.

Still undecided? Editor's Featured Pick

Yucca Health

$146/mo · 7.7/10 · Compounded

If neither Noom Med nor Willow feels like the right fit, our featured pick across all 52 GLP-1 telehealth providers is Yucca Health. It is not the highest-scored provider in our full rankings. We feature it for its low-friction value: a flat $146/mo that stays the same at every dose.

Try Noom Med

Starting at $99/mo

Visit Noom Med

Try Willow

Starting at $299/mo

Visit Willow

Related comparisons

Other matchups readers comparing Noom Med or Willow tend to look at next.

Not sure which one is right for you?

Answer a few quick questions and we'll match you to the best GLP-1 provider for your needs. Or keep exploring below.

Featured Partners

Four affiliate partners we feature, we may earn a commission.

Yucca Health

7.7/10
$146/mo·Compounded

TrimRx

7.8/10
$149/mo·Compounded

Gala

7.2/10
$149/mo·Brand & Compounded

SkinnyRx

7.3/10
$199/mo·Compounded

Affiliate links, we earn a commission at no extra cost to you. These are featured partners, prioritized by our affiliate economics, not an editorial "best" ranking. The objective ranking (by methodology score) and full methodology are at glp1picks.com/best.